MedCision CFT2 ThawSTAR Cryogenic Vial Thawing System - VG Used
MedCision
Details
-
CategoryClinical
-
Dimension4.0in x 4.0in x 6.0in
-
SerialCFT202284
-
Shipping TypeFedEx Ground
-
ManufacturingDoes Not Apply
-
Voltage / HertzDoes Not Apply / Does Not Apply
Description
The MedCision ThawSTAR CFT2 is a cryogenic vial thawing system designed to streamline workflows by providing a reliable and standardized thawing method for cryopreservation processes. This unit effectively mitigates risks associated with non-standard thawing techniques such as using communal water baths or manual hand warming, which can compromise sample integrity and safety. Compatible with most major vial manufacturers, the ThawSTAR accommodates 1.8 to 2.0 mL cryogenic vials with fill volumes ranging from 0.8 to 1.5 mL, achieving complete thawing in under three minutes. Suitable for laboratory and bioprocessing environments, this device enhances efficiency and preserves critical sample quality. Manufactured in the United States, the condition of this used device is classified as Very Good, indicating it functions optimally with minor cosmetic wear. Power cord included, but computer and additional software are not part of this package.
Key Features
- Compatible with major vial manufacturers
- Supports 1.8 to 2.0 mL cryogenic vials
- Thawing time under three minutes
- Standardizes cryopreservation workflow
- Creates less risk of sample compromise
Specifications
- Capacity: 1.8 to 2.0 mL cryogenic vial
- Fill Volume: 0.8 to 1.5 mL
- Compatible with major vial manufacturers
- Thawing Time: Less than three minutes
Weight
Imperial: 2.4 Pounds
Metric: 1.09 Kilograms
Shipping Dimensions
Imperial: 4.8 lb x 4.8 lb x 7.2 lb
Metric: 12.19 cm x 12.19 cm x 18.29 cm
Harmonized Code
841989
Harmonized Code Details
Harmonized code 841989 refers to other machinery, plant or equipment for the treatment of materials by a process involving a change of temperature, justified by the machine's application to cryogenic vial thawing, altering sample conditions.
Comments 0
There are currently no public comments.